Skip to content
stoqly

Corteva

CTVA NYSE Fertilizers & Agricultural Chemicals Financials FY2018–FY2025

Corteva's revenue rose 2.9% to $17.4 billion in fiscal 2025. Its net margin was 6.3%, up from 5.4% a year earlier. Free cash flow was $2.8 billion, up 81.8%. It paid out $1.5 billion in dividends and buybacks, 55% of free cash flow. The diluted share count fell 2.1%.

Last close · Oct 23, 2026

$12.45

3.2%
Value it Compare
Revenue Total sales reported in the income statement.
$17.4B
2.9% vs prior year
Operating margin Operating income as a share of revenue.
—
Net income Profit after all expenses, interest and tax.
$1.1B
20.6%
Free cash flow Cash from operations minus capital spending.
$2.8B
81.8%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
5.8%
1.6 pts
Market cap Last close times the latest diluted share count, so it is approximate.
$8.3B
Oct 23 close
P/E Last close divided by diluted earnings per share over the last four quarters.
8.2x
On $1.52 EPS (TTM)

About these figures. Total debt is the balance sheet's long-term debt plus its current debt line.

What Corteva does

No business description yet.

Legal name
Corteva, Inc.
Fiscal year ends
December 31, 2025
Latest annual report
—
Accession · CIK
0001755672-26-000004
0001755672

Revenue and margins

Corteva had $17.4B of revenue in fiscal 2025, up 2.9% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $2.8B in fiscal 2025, 16.2% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Corteva returned $1.5B to shareholders in fiscal 2025, 55% of free cash flow. The diluted share count fell 2.1%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Value Corteva yourself

Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.

Discounted cash flow

Value per share

—

Adds net cash of $2.0B and divides by 681.4M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.

Earnings multiple

Value per share

—

Reference multiples: today 8.2x · peers 29.6x · sector 20.6x.

Balance sheet

Cash, debt and the ratios that show how comfortably Corteva can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments $4.5B$3.3B$2.7B$3.2B$4.5B
Debt incl. finance leases $1.1B$1.3B$2.5B$2.7B$2.6B
Net debt / EBITDA −1.0x−0.7x−0.1x−0.2x−0.6x
Debt / equity 0.0x0.1x0.1x0.1x0.1x
Interest coverage 79.2x19.1x5.7x6.5x10.4x
Current ratio 1.6x1.6x1.6x1.5x1.4x
Quick ratio 1.1x0.9x0.9x0.9x1.0x
Total assets $42.3B$42.6B$43.0B$40.8B$42.8B
Total liabilities $16.7B$17.1B$17.7B$16.8B$18.5B
Shareholders' equity $25.4B$25.3B$25.0B$23.8B$24.1B
Net debt (− = net cash) −$3.4B−$2.0B−$253M−$466M−$2.0B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.6M

1 insider

Of sales under plans

0%

$0.0M

DateInsiderTradeSharesPriceValueFiling
Feb 20, 2026 Brian TitusSee Remarks Sold 8,311 $76.55 $0.6M Form 4

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY23FY24FY25
Net income is positive ✓ ✓ ✓
Cash from operations is positive ✓ ✓ ✓
Return on assets rose ✕ ✓ ✓
Cash from operations exceeds net income ✓ ✓ ✓
Debt fell relative to assets ✕ ✕ ✓
Current ratio rose ✕ ✕ ✕
Share count didn't rise ✓ ✓ ✓
Gross margin rose ✓ ✓ ✓
Revenue rose relative to assets ✕ ✕ ✓
F-score 5 / 96 / 98 / 9
Accruals ratio −2.4%−3.0%−5.5%
Altman Z'' 2.602.512.47

Similar companies

Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.

CompanyMarket capGrowthOp. marginFCF marginROICP/EF-score
Corteva CTVA $8.3B 2.9% — 16.2% 5.8% 8.2x 8
Mosaic MOS $5.7B 8.4% 6.8% −4.4% 2.5% — 8 Compare →
CF Industries CF $18.6B 19.3% 32.5% 25.4% 20.6% 9.0x 8 Compare →
FMC FMC $633M −18.3% −47.0% −3.0% −19.6% — 2 Compare →
Scotts Miracle-Gro SMG $3.5B −3.9% 10.5% 8.0% 13.4% 50.3x 6 Compare →

8 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue $14.3B $13.8B $14.2B $15.7B $17.5B $17.2B $16.9B $17.4B
Gross profit $4.3B $5.3B $5.7B $6.4B $7.0B $7.3B $7.4B $8.2B
Research and development $1.4B $1.1B $1.1B $1.2B $1.2B $1.3B $1.4B $1.5B
Interest expense $337M $136M $45.0M $30.0M $79.0M $233M $233M $180M
Pretax income −$6.8B −$316M $675M $2.3B $1.4B $1.1B $1.3B $1.7B
Income tax −$31.0M −$46.0M −$81.0M $524M $210M $152M $412M $484M
Net income −$5.1B −$959M $681M $1.8B $1.1B $735M $907M $1.1B
Diluted EPS −$6.76 −$1.28 $0.91 $2.37 $1.58 $1.03 $1.30 $1.60
Diluted shares 0.75B 0.75B 0.75B 0.74B 0.72B 0.71B 0.70B 0.68B
Cash flow
Cash from operations $483M $1.1B $2.1B $2.7B $872M $1.8B $2.1B $3.4B
Capital expenditure $1.5B $1.2B $475M $573M $605M $595M $597M $591M
Free cash flow −$1.0B −$93.0M $1.6B $2.2B $267M $1.2B $1.5B $2.8B
Depreciation and amortization $2.8B $1.6B $1.2B $1.2B $1.2B $1.2B $1.2B $1.2B
Acquisitions $0.0M $10.0M $0.0M $0.0M $0.0M $1.5B $0.0M $0.0M
Share buybacks $0.0M $25.0M $275M $950M $1.0B $756M $1.0B $1.1B
Dividends paid $0.0M $194M $388M $397M $418M $439M $458M $475M
Dividends and buybacks $0.0M $219M $663M $1.3B $1.4B $1.2B $1.5B $1.5B
Balance sheet
Cash and short-term investments $2.3B $1.8B $3.8B $4.5B $3.3B $2.7B $3.2B $4.5B
Total debt $7.9B $122M $1.1B $1.1B $1.3B $2.5B $2.7B $2.6B
Finance lease liabilities $92.0M $9.0M $5.0M $4.0M $3.0M $2.0M $0.0M $0.0M
Current assets $23.0B $13.5B $14.8B $15.5B $16.8B $16.3B $15.1B $17.3B
Current liabilities $13.3B $8.2B $8.5B $9.6B $10.7B $10.4B $10.4B $12.1B
Inventory $5.3B $5.0B $4.9B $5.2B $6.8B $6.9B $5.4B $5.7B
Property and equipment, net $4.5B $4.5B $4.4B $4.3B $4.3B $4.3B $4.1B $4.2B
Total assets $108.7B $42.4B $42.6B $42.3B $42.6B $43.0B $40.8B $42.8B
Total liabilities $33.5B $17.8B $17.6B $16.7B $17.1B $17.7B $16.8B $18.5B
Shareholders' equity $74.7B $24.3B $24.8B $25.4B $25.3B $25.0B $23.8B $24.1B
Margins
Gross margin 30.4% 38.1% 40.2% 41.1% 40.2% 42.4% 43.6% 47.3%
EBITDA margin −25.8% 10.3% 13.3% 23.1% 15.6% 14.7% 16.2% 17.7%
Net margin −35.5% −6.9% 4.8% 11.2% 6.6% 4.3% 5.4% 6.3%
FCF margin −7.1% −0.7% 11.2% 13.8% 1.5% 6.8% 9.2% 16.2%
Returns
Return on capital — −0.3% 3.2% 8.3% 5.6% 4.7% 4.2% 5.8%
Return on capital employed — −0.3% 2.1% 7.1% 4.7% 4.1% 4.8% 6.1%
Return on equity — −1.9% 2.8% 7.0% 4.5% 2.9% 3.7% 4.6%
Return on assets — −1.3% 1.6% 4.1% 2.7% 1.7% 2.2% 2.6%
Growth
Revenue growth — −3.1% 2.7% 10.1% 11.5% −1.3% −1.9% 2.9%
Net income growth — — — 158.3% −34.8% −35.9% 23.4% 20.6%
EPS growth — — — 160.4% −33.3% −34.8% 26.2% 23.1%
FCF growth — — — 35.6% −87.6% 339.7% 31.9% 81.9%
Share count change — 0.0% 0.2% −1.3% −2.3% −1.7% −2.2% −2.1%
Financial health
Net debt / EBITDA — −1.2x −1.4x −1.0x −0.7x −0.1x −0.2x −0.6x
Debt / equity 0.1x 0.0x 0.0x 0.0x 0.1x 0.1x 0.1x 0.1x
Interest coverage −19.2x −1.3x 16.0x 79.2x 19.1x 5.7x 6.5x 10.4x
Current ratio 1.7x 1.6x 1.7x 1.6x 1.6x 1.6x 1.5x 1.4x
Quick ratio 1.3x 1.0x 1.2x 1.1x 0.9x 0.9x 0.9x 1.0x
Capital allocation
Capex / revenue 10.5% 8.4% 3.3% 3.7% 3.5% 3.5% 3.5% 3.4%
Payouts / FCF — — 41.7% 62.5% 531.1% 101.8% 94.8% 54.9%
Quality scores
Piotroski F-score — — 7.0 7.0 4.0 5.0 6.0 8.0
Altman Z'' 2.5 2.2 2.6 3.0 2.8 2.6 2.5 2.5
Accruals ratio — −2.7% −3.3% −2.3% 0.7% −2.4% −3.0% −5.5%

Source: SEC EDGAR XBRL filings (CIK 0001755672). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open